Showing results (181-190 of 286) with videos related to
Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|June 4, 2026
Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsamplingVictor Amajor, Amanda Bwint, Steven L Shein, et al.The Journal of Pediatrics|April 13, 2012
Fatal and near-fatal asthma in children: the critical care perspectiveChristopher J L Newth, Kathleen L Meert, Amy E Clark, et al.Pediatric Blood & Cancer|January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium studyLars M Wagner, John P Perentesis, Joel M Reid, et al.Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium studyYael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.Msystems|November 29, 2024
Proteomic profiling of the local and systemic immune response to pediatric respiratory viral infectionsEmily Lydon, Christina M Osborne, Brandie D Wagner, et al.Pediatric Blood & Cancer|September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology GroupBrigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.Pediatric Blood & Cancer|July 1, 2010
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group studyRani E George, Jill M Lahti, Peter C Adamson, et al.Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.Journal of the National Cancer Institute|April 5, 2017
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH TrialCarl E Allen, Theodore W Laetsch, Rajen Mody, et al.Pageof 29